FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

Enforcement Actions Decline at CDRH

[ Price : $8.95]

CDRH director Daniel Schultz presents enforcement data at an industry meeting showing a decline in actions this fiscal year.

Industry Role in New FDA Ads Web Site Not Bad

[ Price : $8.95]

FDA defends its use of a drug industry-connected third party in establishing its new Web site on how consumers can detect and rep...

Woodcock Still Bullish on Critical Path

[ Price : $8.95]

Four years after FDAs critical path initiative began, CDER director Janet Woodcock assesses progress-to-date and expresses optimis...

Schultz: People Angry, But LASIK Strategy Coming

[ Price : $8.95]

CDRH director Daniel Schultz tells FDA Webview that while he recognizes there is an information vacuum about LASIK and a lot of an...

Technetium Market Shortages Projected

[ Price : $8.95]

Covidien says there will be some shortages of TechneLite generators this month due to problems at three of five medical isotope re...

Pfizer Launches Drug Safety Web Site

[ Price : $8.95]

Pfizer launches an interactive drug safety Web site to educate professionals and consumers.

Ban Commercial CME Support: Public Citizen

[ Price : $8.95]

Public Citizen says it supports an Accreditation Council for Continuing Medical Education proposal to end commercial support of CM...

Animal Drug User Fees Out

[ Price : $8.95]

FDA publishes FY 2009 animal drug and generic animal drug user fee rates.

Are FDAs Communications Understood?

[ Price : $8.95]

Members of FDAs Risk Communication Advisory Committee say FDA communications may not always be understood by their intended audien...

FDA Opens Docket on LASIK Experience

[ Price : $8.95]

Federal Register Notice: FDA opens a public docket to receive information and comments on post-market experience associated LASIK ...